Malaysia's health ministry said on Friday it has granted conditional approval for emergency use to the COVID-19 vaccine manufactured by China's Sinopharm, Reuters reported. The Sinopharm vaccine in Malaysia was registered by pharmaceutical company Duopharma Sdn Bhd, Director-General of Health Noor Hisham Abdullah said in a statement. Duopharma had previously announced a deal to supply the Malaysian government with 6.4 million doses of the Russian-made Sputnik V vaccine.